MedTrace Logo

Recurrent Visceral Leishmaniasis in HIV Co-Infection

NCT07487350 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-03-23

No results posted yet for this study

Summary

The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients living with HIV and (2) to improve treatment monitoring of this target group in Ethiopia

Conditions

  • Hiv
  • Visceral Leishmaniasis

Sponsors & Collaborators

  • Armauer Hansen Research Institute, Ethiopia

    collaborator OTHER

  • University of Gondar

    collaborator OTHER

  • Institute of Tropical Medicine, Belgium

    lead OTHER

Principal Investigators

  • Eleni Ayele · LRTC University of Gondar

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-21
Primary Completion
2027-04-30
Completion
2027-12-31

Countries

  • Ethiopia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07487350 on ClinicalTrials.gov